Recruiting

Observational Study

Sponsor:

Miro Health

Code:

NCT04438967

Conditions

Brain Health

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

This is a nationwide research program to study the neurological effects of COVID-19. It is open to the public. Healthy individuals and individuals who are or have been infected with COVID-19 are encouraged to join the effort. The study can be done at home with internet access and an iPad or iPhone. Participation takes about one hour.

To learn more, go to https://www.mirohealth.com/consent/

Conditions

Brain Health

Study ID

NCT04438967

Start date

Jun 16, 2020

Status verified date

Jan, 2021

Completion date

Dec 31, 2021

Anticipated

Primary completion date

Dec 31, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • 18 years of age or older
  • Access to an iPad bought in 2013 or later
  • Access to stable Wi-Fi
  • Access to iTunes

Exclusion Criteria for healthy:

  • Below age 18
  • Preexisting neurological, psychiatric, or developmental disorder

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Test the hypothesis that COVID-19 infection will lead to increased risk of neurological impairment [ Time Frame: ~1 year ]
  • Determine cognitive and behavioral functional patterns that predict susceptibility to neurological impairment due to COVID-19 [ Time Frame: ~1 year ]

Central Contacts and Locations

Central contacts

Natasha Belfor, PhD

415-655-3839research@mirohealth.com

Locations

Miro Health

Recruiting

San Francisco, California, United States, 94107

Contacts

Shenly Glenn, BS

415-317-3939research@mirohealth.com

More Information

Sponsor

Miro Health

Last update posted

Jan 6, 2021

Last verified

Jan, 2021

Keywords

  • COVID-19
  • neurocognitive
  • stroke
  • nervous system

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Miro Health on 2021-01-06.